PL3689341T3 - Gabapentyna okulistyczna do leczenia deepitelializacji rogówki - Google Patents

Gabapentyna okulistyczna do leczenia deepitelializacji rogówki

Info

Publication number
PL3689341T3
PL3689341T3 PL20160507.8T PL20160507T PL3689341T3 PL 3689341 T3 PL3689341 T3 PL 3689341T3 PL 20160507 T PL20160507 T PL 20160507T PL 3689341 T3 PL3689341 T3 PL 3689341T3
Authority
PL
Poland
Prior art keywords
epithelialization
gabapentin
corneal
ophthalmic
treatment
Prior art date
Application number
PL20160507.8T
Other languages
English (en)
Inventor
Piero Biondi
Edoardo Stagni
Original Assignee
Fidia Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici S.P.A. filed Critical Fidia Farmaceutici S.P.A.
Publication of PL3689341T3 publication Critical patent/PL3689341T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20160507.8T 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia deepitelializacji rogówki PL3689341T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000121A ITUB20160121A1 (it) 2016-01-29 2016-01-29 Gabapentina oftalmica per il trattamento di ulcere corneali

Publications (1)

Publication Number Publication Date
PL3689341T3 true PL3689341T3 (pl) 2024-04-22

Family

ID=55860930

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17703933T PL3407879T3 (pl) 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia wrzodów rogówki
PL20160507.8T PL3689341T3 (pl) 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia deepitelializacji rogówki

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17703933T PL3407879T3 (pl) 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia wrzodów rogówki

Country Status (8)

Country Link
EP (2) EP3407879B1 (pl)
AR (1) AR107460A1 (pl)
ES (2) ES2971979T3 (pl)
IT (1) ITUB20160121A1 (pl)
PL (2) PL3407879T3 (pl)
PT (1) PT3407879T (pl)
SM (1) SMT202100183T1 (pl)
WO (1) WO2017129577A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2664693C1 (ru) * 2017-10-05 2018-08-21 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ предоперационной подготовки пациентов к офтальмологическим операциям
EP4192247A4 (en) * 2020-08-04 2025-01-08 Harrow IP, LLC Antibacterial compositions and methods for fabricating thereof
EP4297741A4 (en) * 2021-02-26 2025-02-26 Vyluma Inc. METHODS AND FORMULATIONS FOR TOPICAL ADMINISTRATION OF GABAPENTINOIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2316420B1 (en) * 2009-10-22 2014-02-26 Consorzio Universitario Unifarm Topical ophthalmic composition to reduce pain
EP2851063A1 (en) 2013-09-19 2015-03-25 Consorzio Universitario Unifarm Gabapentin compositions for treating or preventing ocular pain

Also Published As

Publication number Publication date
WO2017129577A1 (en) 2017-08-03
EP3689341A1 (en) 2020-08-05
ES2862324T3 (es) 2021-10-07
EP3407879B1 (en) 2021-01-06
AR107460A1 (es) 2018-05-02
ES2971979T3 (es) 2024-06-10
ITUB20160121A1 (it) 2017-07-29
PL3407879T3 (pl) 2021-06-28
SMT202100183T1 (it) 2021-05-07
EP3407879A1 (en) 2018-12-05
EP3689341B1 (en) 2023-12-20
PT3407879T (pt) 2021-03-31
WO2017129577A8 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
IL288712A (en) Methods for treating abnormal movement disorders
PL3122878T3 (pl) TERAPIA mRNA DO LECZENIA CHORÓB OCZU
IL248732B (en) Compounds for the treatment of ophthalmological diseases and disorders
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3212233A4 (en) Combination therapy for treatment of disease
SG11201608729RA (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
HUE066769T2 (hu) Neurodegeneratív szembetegség kezelése pridopidinnal
SMT202100082T1 (it) Composti eteroarilici per il trattamento di malattie oftalmiche
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
IL269698B (en) Methods for preventing or treating eye diseases
HUE070257T2 (hu) Vegyületek a lipofuscinhoz kapcsolódó betegségek kezelésére
IL259381B (en) Mirabegron for the treatment of retinal diseases
PL3407879T3 (pl) Gabapentyna okulistyczna do leczenia wrzodów rogówki
EP3284475A4 (en) Agent for prevention or treatment of corneal disorders
IL263837A (en) Treatment of ocular disease
EP3238723A4 (en) Drug for treating disorders of corneal epithelium
LT3903774T (lt) N,n-bis-2-merkaptoetilizoftalamidas, skirtas neurodegeneracinių ligų gydymui
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
GB201610938D0 (en) Treatment of ocular disease